BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1
15 results:

  • 1. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
    Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
    Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Attention-guided multi-scale context aggregation network for multi-modal brain glioma segmentation.
    Wu S; Cao Y; Li X; Liu Q; Ye Y; Liu X; Zeng L; Tian M
    Med Phys; 2023 Dec; 50(12):7629-7640. PubMed ID: 37151131
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Convolutional Neural Network with Multiscale Fusion and Attention Mechanism for Skin Diseases Assisted Diagnosis.
    Li Z; Wang H; Han Q; Liu J; Hou M; Chen G; Tian Y; Weng T
    Comput Intell Neurosci; 2022; 2022():8390997. PubMed ID: 35747726
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cinnamaldehyde Downregulation of sept9 Inhibits Glioma Progression through Suppressing Hif-1
    Wang Z; Wang C; Fu J; Liu R; Zhou X
    Dis Markers; 2022; 2022():6530934. PubMed ID: 35096204
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Small, Smart, and LDLR-Specific Micelles Augment Sorafenib Therapy of Glioblastoma.
    Wei J; Xia Y; Meng F; Ni D; Qiu X; Zhong Z
    Biomacromolecules; 2021 Nov; 22(11):4814-4822. PubMed ID: 34677048
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CircRNA sept9 contributes to malignant behaviors of glioma cells via miR-432-5p-mediated regulation of LASP1.
    Yue L; Wang G; Zhu M
    Brain Res; 2021 Sep; 1766():147501. PubMed ID: 33915163
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Biomarker-guided heterogeneity analysis of genetic regulations via multivariate sparse fusion.
    Zhang S; Hu X; Luo Z; Jiang Y; Sun Y; Ma S
    Stat Med; 2021 Jul; 40(17):3915-3936. PubMed ID: 33906263
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CDC42EP5/BORG3 modulates sept9 to promote actomyosin function, migration, and invasion.
    Farrugia AJ; Rodríguez J; Orgaz JL; Lucas M; Sanz-Moreno V; Calvo F
    J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32798219
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Down-regulation of sept9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).
    Zhang G; Feng W; Wu J
    Biomed Pharmacother; 2020 May; 125():109768. PubMed ID: 32106387
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
    Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
    J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
    Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
    Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Human septin 3 on chromosome 22q13.2 is upregulated by neuronal differentiation.
    Methner A; Leypoldt F; Joost P; Lewerenz J
    Biochem Biophys Res Commun; 2001 Apr; 283(1):48-56. PubMed ID: 11322766
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Melanocyte-specific gene expression: role of repression and identification of a melanocyte-specific factor, msf.
    Yavuzer U; Goding CR
    Mol Cell Biol; 1994 May; 14(5):3494-503. PubMed ID: 8164694
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (msf): implications for cancer pathogenesis.
    Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
    EXS; 1991; 59():127-46. PubMed ID: 1833226
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)].
    Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK
    Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.